Irritable Bowel Syndrome
News, opinions and meeting coverage in gastroenterology.
<ѻýҕl>No Approval for Rifaximin in IBSѻýҕl>
The FDA has indicated that, before the antibiotic drug rifaximin (Xifaxan) can be approved for treating irritable bowel syndrome, its manufacturer must provide data on how the agent should be used in retreating patients with recurrent symptoms, the company said.
Mar 08, 2011
<ѻýҕl>Heart Risk Prompts FDA to Pull IBS Agent Tegaserod (Zelnorm)ѻýҕl>
ROCKVILLE, Md. -- The FDA said today that Novartis has halted sales of tegaserod (Zelnorm), its agent for irritable bowel syndrome and constipation, following suggestions of a small increase in ischemic events, including angina and stroke, in those taking the drug.
Mar 30, 2007
<ѻýҕl>DDW: Constipation Drug Seen Safe and Effective for Long Term Use in Elderlyѻýҕl>
Los Angeles — The new medication Amitiza (lubiprostone) is safe and effective as long-term therapy for chronic constipation in older patients, researchers reported here. Results were at least as good in seniors as in the more general populations studied earlier.
May 23, 2006